Latest quarterly figures published for emergency presentations of cancer

The National Cancer Registration and Analysis Services (NCRAS) has published quarterly data for its two cancer outcome metrics.

Emergency Presentations
This metric shows the estimated proportion of all malignant cancers (excluding non-melanoma skin cancer) which present as an emergency.

This data is available at a Clinical Commissioning Group (CCG) level with the option to select a reference CCG alongside your chosen CCG.

Between October and December 2016, of 66,379 cancer patients who first presented in hospital, 12,678 (19.1 per cent) presented as an emergency.  This is a fall of 0.9 per cent from the previous quarter (July to September 2016).

Over the past three years the proportion of cancer patients presenting as an emergency has fallen for 123 CCGs, and either risen or remained unchanged for 86 CCGs.

The emergency presentation data is available here and a commentary on the data can be viewed here.

Stage at Diagnosis
This metric shows the proportion of ten cancer types (listed here) diagnosed in each quarter and what stage they are at the time of diagnosis.  The workbook can be viewed here.

Page published: Fri 28 July 2017

It is supported by 8 companies:

  • Amgen
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Lilly
  • Novartis
  • Pfizer
  • Roche